SEC Comment Letter 0000000000-23-002671 to PINEAPPLE EXPRESS CANNABIS Co (PNXP) (CIK 0001710495) (PNXP)
PINEAPPLE EXPRESS CANNABIS Co (PNXP) (CIK 0001710495)
Date: March 17, 2023 · CIK: 0001710495 · Accession: 0000000000-23-002671
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
March 17, 2023
Matthew Feinstein
Chief Executive Officer
Pineapple Express Cannabis Company
10351 Santa Monica Blvd., Suite 420
Los Angeles, CA 90025
Re:Pineapple Express Cannabis Company
Schedule 13D filed by Matthew Feinstein
Filed March 1, 2023
Filed No. 005-94003
Dear Matthew Feinstein:
We have reviewed the above-captioned filing, and have the following comment.
Please respond to this letter by amending the filing or by providing the requested
information. If a belief exists that our comment does not apply to your facts and circumstances or
that an amendment is inappropriate, please advise us why in a response letter.
After reviewing any amendment to the filing and any information provided in response
to this comment, we may have additional comments.
Schedule 13D filed March 1, 2023
General
1.We note the date of the event reported as requiring the filing of the Schedule 13D was
December 18, 2022. Rule 13d-1(a) of Regulation 13D-G requires the filing of a Schedule
13D within 10 days after the acquisition of more than five percent of a class of equity
securities specified in Rule 13d-1(i). Based on the December 18, 2022 event date, the
Schedule 13D submitted on March 1, 2023 was not timely filed. Please advise us why the
Schedule 13D was not filed within the required 10 days after the acquisition.
We remind you that the filing persons are responsible for the accuracy and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
FirstName LastNameMatthew Feinstein
Comapany NamePineapple Express Cannabis Company
March 17, 2023 Page 2
FirstName LastName
Matthew Feinstein
Pineapple Express Cannabis Company
March 17, 2023
Page 2
Please direct any questions to Michael Killoy at (202) 551-7576 or Nicholas Panos at
(202) 551-3266.
Sincerely,
Division of Corporation Finance
Office of Mergers & Acquisitions